Some Popular Antipsychotics May Not be Effective in Patients over 40
The Carlat Psychiatry Report, Volume 11, Number 1, January 2013
https://www.thecarlatreport.com/newsletter-issue/tcprv11n1/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics
Glen Spielmans, PhD
Associate professor of psychology, Metropolitan State University, St. Paul, MN
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.
Atypical antipsychotics are widely prescribed for a number of psychiatric diagnoses, but their real-world effectiveness has rarely been evaluated in anything other than short-term trials. A recently published study finds that four commonly used antipsychotics (aripiprazole [Abilify], olanzapine [Zyprexa], quetiapine [Seroquel], and risperidone [Risperdal]), when used in patients over age 40 with schizophrenia or psychosis associated with other conditions, may not be effective—and cause frequent side effects.
You can't view details of this content, please login or buy subscription here